ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Prostacyclin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-37Q8793
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Prostacyclin Market Outlook 2022
BUY CHAPTERS

Prostacyclin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-37Q8793
Report
August 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
United Therapeutics
Actelion (J & J)
GSK
TEVA
Toray
Tide Pharma
Bayer
Actelion (J & J)

Prostacyclin- Market Size

The global market for Prostacyclin was estimated to be worth US$ 2712 million in 2024 and is forecast to a readjusted size of US$ 4355 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.

Prostacyclin- Market

Prostacyclin- Market

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
This report aims to provide a comprehensive presentation of the global market for Prostacyclin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Prostacyclin by region & country, by Type, and by Application.
The Prostacyclin market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostacyclin.
Market Segmentation

Scope of Prostacyclin- Market Report

Report Metric Details
Report Name Prostacyclin- Market
Forecasted market size in 2031 US$ 4355 million
CAGR 7.1%
Forecasted years 2025 - 2031
Segment by Type
  • Epoprostenol Sodium
  • Treprostinil
  • Iloprost
  • Beraprost Sodium
Segment by Application
  • For Injection
  • For Oral
  • For Inhalation
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Prostacyclin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Prostacyclin in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Prostacyclin- Market size in 2031?

Ans: The Prostacyclin- Market size in 2031 will be US$ 4355 million.

What is the United Therapeutics share in Prostacyclin- Market?

Ans: United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.

What is the Prostacyclin- Market share by type?

Ans: In terms of product, Beraprost Sodium is the largest segment, with a share over 50%.

Who are the main players in the Prostacyclin- Market report?

Ans: The main players in the Prostacyclin- Market are United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG

What are the Application segmentation covered in the Prostacyclin- Market report?

Ans: The Applications covered in the Prostacyclin- Market report are For Injection, For Oral, For Inhalation

What are the Type segmentation covered in the Prostacyclin- Market report?

Ans: The Types covered in the Prostacyclin- Market report are Epoprostenol Sodium, Treprostinil, Iloprost, Beraprost Sodium

1 Market Overview
1.1 Prostacyclin Product Introduction
1.2 Global Prostacyclin Market Size Forecast
1.2.1 Global Prostacyclin Sales Value (2020-2031)
1.2.2 Global Prostacyclin Sales Volume (2020-2031)
1.2.3 Global Prostacyclin Sales Price (2020-2031)
1.3 Prostacyclin Market Trends & Drivers
1.3.1 Prostacyclin Industry Trends
1.3.2 Prostacyclin Market Drivers & Opportunity
1.3.3 Prostacyclin Market Challenges
1.3.4 Prostacyclin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prostacyclin Players Revenue Ranking (2024)
2.2 Global Prostacyclin Revenue by Company (2020-2025)
2.3 Global Prostacyclin Players Sales Volume Ranking (2024)
2.4 Global Prostacyclin Sales Volume by Company Players (2020-2025)
2.5 Global Prostacyclin Average Price by Company (2020-2025)
2.6 Key Manufacturers Prostacyclin Manufacturing Base and Headquarters
2.7 Key Manufacturers Prostacyclin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Prostacyclin
2.9 Prostacyclin Market Competitive Analysis
2.9.1 Prostacyclin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Prostacyclin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostacyclin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Epoprostenol Sodium
3.1.2 Treprostinil
3.1.3 Iloprost
3.1.4 Beraprost Sodium
3.2 Global Prostacyclin Sales Value by Type
3.2.1 Global Prostacyclin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Prostacyclin Sales Value, by Type (2020-2031)
3.2.3 Global Prostacyclin Sales Value, by Type (%) (2020-2031)
3.3 Global Prostacyclin Sales Volume by Type
3.3.1 Global Prostacyclin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Prostacyclin Sales Volume, by Type (2020-2031)
3.3.3 Global Prostacyclin Sales Volume, by Type (%) (2020-2031)
3.4 Global Prostacyclin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 For Injection
4.1.2 For Oral
4.1.3 For Inhalation
4.2 Global Prostacyclin Sales Value by Application
4.2.1 Global Prostacyclin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Prostacyclin Sales Value, by Application (2020-2031)
4.2.3 Global Prostacyclin Sales Value, by Application (%) (2020-2031)
4.3 Global Prostacyclin Sales Volume by Application
4.3.1 Global Prostacyclin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Prostacyclin Sales Volume, by Application (2020-2031)
4.3.3 Global Prostacyclin Sales Volume, by Application (%) (2020-2031)
4.4 Global Prostacyclin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Prostacyclin Sales Value by Region
5.1.1 Global Prostacyclin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Prostacyclin Sales Value by Region (2020-2025)
5.1.3 Global Prostacyclin Sales Value by Region (2026-2031)
5.1.4 Global Prostacyclin Sales Value by Region (%), (2020-2031)
5.2 Global Prostacyclin Sales Volume by Region
5.2.1 Global Prostacyclin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Prostacyclin Sales Volume by Region (2020-2025)
5.2.3 Global Prostacyclin Sales Volume by Region (2026-2031)
5.2.4 Global Prostacyclin Sales Volume by Region (%), (2020-2031)
5.3 Global Prostacyclin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Prostacyclin Sales Value, 2020-2031
5.4.2 North America Prostacyclin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Prostacyclin Sales Value, 2020-2031
5.5.2 Europe Prostacyclin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Prostacyclin Sales Value, 2020-2031
5.6.2 Asia Pacific Prostacyclin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Prostacyclin Sales Value, 2020-2031
5.7.2 South America Prostacyclin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Prostacyclin Sales Value, 2020-2031
5.8.2 Middle East & Africa Prostacyclin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prostacyclin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Prostacyclin Sales Value
6.2.1 Key Countries/Regions Prostacyclin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Prostacyclin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Prostacyclin Sales Value, 2020-2031
6.3.2 United States Prostacyclin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Prostacyclin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Prostacyclin Sales Value, 2020-2031
6.4.2 Europe Prostacyclin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Prostacyclin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Prostacyclin Sales Value, 2020-2031
6.5.2 China Prostacyclin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Prostacyclin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Prostacyclin Sales Value, 2020-2031
6.6.2 Japan Prostacyclin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Prostacyclin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Prostacyclin Sales Value, 2020-2031
6.7.2 South Korea Prostacyclin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Prostacyclin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Prostacyclin Sales Value, 2020-2031
6.8.2 Southeast Asia Prostacyclin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Prostacyclin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Prostacyclin Sales Value, 2020-2031
6.9.2 India Prostacyclin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Prostacyclin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 United Therapeutics
7.1.1 United Therapeutics Company Information
7.1.2 United Therapeutics Introduction and Business Overview
7.1.3 United Therapeutics Prostacyclin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 United Therapeutics Prostacyclin Product Offerings
7.1.5 United Therapeutics Recent Development
7.2 Actelion (J & J)
7.2.1 Actelion (J & J) Company Information
7.2.2 Actelion (J & J) Introduction and Business Overview
7.2.3 Actelion (J & J) Prostacyclin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Actelion (J & J) Prostacyclin Product Offerings
7.2.5 Actelion (J & J) Recent Development
7.3 GSK
7.3.1 GSK Company Information
7.3.2 GSK Introduction and Business Overview
7.3.3 GSK Prostacyclin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 GSK Prostacyclin Product Offerings
7.3.5 GSK Recent Development
7.4 Teva
7.4.1 Teva Company Information
7.4.2 Teva Introduction and Business Overview
7.4.3 Teva Prostacyclin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Teva Prostacyclin Product Offerings
7.4.5 Teva Recent Development
7.5 Toray
7.5.1 Toray Company Information
7.5.2 Toray Introduction and Business Overview
7.5.3 Toray Prostacyclin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Toray Prostacyclin Product Offerings
7.5.5 Toray Recent Development
7.6 Tide Pharma
7.6.1 Tide Pharma Company Information
7.6.2 Tide Pharma Introduction and Business Overview
7.6.3 Tide Pharma Prostacyclin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Tide Pharma Prostacyclin Product Offerings
7.6.5 Tide Pharma Recent Development
7.7 Bayer AG
7.7.1 Bayer AG Company Information
7.7.2 Bayer AG Introduction and Business Overview
7.7.3 Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bayer AG Prostacyclin Product Offerings
7.7.5 Bayer AG Recent Development
8 Industry Chain Analysis
8.1 Prostacyclin Industrial Chain
8.2 Prostacyclin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prostacyclin Sales Model
8.5.2 Sales Channel
8.5.3 Prostacyclin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
United Therapeutics
Actelion (J & J)
GSK
TEVA
Toray
Tide Pharma
Bayer
Actelion (J & J)
List of Tables
 Table 1. Prostacyclin Market Trends
 Table 2. Prostacyclin Market Drivers & Opportunity
 Table 3. Prostacyclin Market Challenges
 Table 4. Prostacyclin Market Restraints
 Table 5. Global Prostacyclin Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Prostacyclin Revenue Market Share by Company (2020-2025)
 Table 7. Global Prostacyclin Sales Volume by Company (2020-2025) & (K Unit)
 Table 8. Global Prostacyclin Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Prostacyclin Price by Company (2020-2025) & (USD/Unit)
 Table 10. Key Manufacturers Prostacyclin Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Prostacyclin Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Prostacyclin
 Table 13. Global Prostacyclin Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostacyclin as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prostacyclin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Prostacyclin Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Prostacyclin Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Prostacyclin Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Prostacyclin Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Prostacyclin Sales Volume by Type: 2020 VS 2024 VS 2031 (K Unit)
 Table 22. Global Prostacyclin Sales Volume by Type (2020-2025) & (K Unit)
 Table 23. Global Prostacyclin Sales Volume by Type (2026-2031) & (K Unit)
 Table 24. Global Prostacyclin Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Prostacyclin Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Prostacyclin Price by Type (2020-2025) & (USD/Unit)
 Table 27. Global Prostacyclin Price by Type (2026-2031) & (USD/Unit)
 Table 28. Global Prostacyclin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Prostacyclin Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Prostacyclin Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Prostacyclin Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Prostacyclin Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Prostacyclin Sales Volume by Application: 2020 VS 2024 VS 2031 (K Unit)
 Table 34. Global Prostacyclin Sales Volume by Application (2020-2025) & (K Unit)
 Table 35. Global Prostacyclin Sales Volume by Application (2026-2031) & (K Unit)
 Table 36. Global Prostacyclin Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Prostacyclin Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Prostacyclin Price by Application (2020-2025) & (USD/Unit)
 Table 39. Global Prostacyclin Price by Application (2026-2031) & (USD/Unit)
 Table 40. Global Prostacyclin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Prostacyclin Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Prostacyclin Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Prostacyclin Sales Value by Region (2020-2025) & (%)
 Table 44. Global Prostacyclin Sales Value by Region (2026-2031) & (%)
 Table 45. Global Prostacyclin Sales Volume by Region (K Unit): 2020 VS 2024 VS 2031
 Table 46. Global Prostacyclin Sales Volume by Region (2020-2025) & (K Unit)
 Table 47. Global Prostacyclin Sales Volume by Region (2026-2031) & (K Unit)
 Table 48. Global Prostacyclin Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Prostacyclin Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Prostacyclin Average Price by Region (2020-2025) & (USD/Unit)
 Table 51. Global Prostacyclin Average Price by Region (2026-2031) & (USD/Unit)
 Table 52. Key Countries/Regions Prostacyclin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Prostacyclin Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Prostacyclin Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Prostacyclin Sales Volume, (2020-2025) & (K Unit)
 Table 56. Key Countries/Regions Prostacyclin Sales Volume, (2026-2031) & (K Unit)
 Table 57. United Therapeutics Company Information
 Table 58. United Therapeutics Introduction and Business Overview
 Table 59. United Therapeutics Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 60. United Therapeutics Prostacyclin Product Offerings
 Table 61. United Therapeutics Recent Development
 Table 62. Actelion (J & J) Company Information
 Table 63. Actelion (J & J) Introduction and Business Overview
 Table 64. Actelion (J & J) Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 65. Actelion (J & J) Prostacyclin Product Offerings
 Table 66. Actelion (J & J) Recent Development
 Table 67. GSK Company Information
 Table 68. GSK Introduction and Business Overview
 Table 69. GSK Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 70. GSK Prostacyclin Product Offerings
 Table 71. GSK Recent Development
 Table 72. Teva Company Information
 Table 73. Teva Introduction and Business Overview
 Table 74. Teva Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 75. Teva Prostacyclin Product Offerings
 Table 76. Teva Recent Development
 Table 77. Toray Company Information
 Table 78. Toray Introduction and Business Overview
 Table 79. Toray Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Toray Prostacyclin Product Offerings
 Table 81. Toray Recent Development
 Table 82. Tide Pharma Company Information
 Table 83. Tide Pharma Introduction and Business Overview
 Table 84. Tide Pharma Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 85. Tide Pharma Prostacyclin Product Offerings
 Table 86. Tide Pharma Recent Development
 Table 87. Bayer AG Company Information
 Table 88. Bayer AG Introduction and Business Overview
 Table 89. Bayer AG Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 90. Bayer AG Prostacyclin Product Offerings
 Table 91. Bayer AG Recent Development
 Table 92. Key Raw Materials Lists
 Table 93. Raw Materials Key Suppliers Lists
 Table 94. Prostacyclin Downstream Customers
 Table 95. Prostacyclin Distributors List
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources


List of Figures
 Figure 1. Prostacyclin Product Picture
 Figure 2. Global Prostacyclin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Prostacyclin Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Prostacyclin Sales Volume (2020-2031) & (K Unit)
 Figure 5. Global Prostacyclin Sales Price (2020-2031) & (USD/Unit)
 Figure 6. Prostacyclin Report Years Considered
 Figure 7. Global Prostacyclin Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Prostacyclin Players Sales Volume Ranking (2024) & (K Unit)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostacyclin Revenue in 2024
 Figure 10. Prostacyclin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Epoprostenol Sodium Picture
 Figure 12. Treprostinil Picture
 Figure 13. Iloprost Picture
 Figure 14. Beraprost Sodium Picture
 Figure 15. Global Prostacyclin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 16. Global Prostacyclin Sales Value Market Share by Type, 2024 & 2031
 Figure 17. Global Prostacyclin Sales Volume by Type (2020 VS 2024 VS 2031) & (K Unit)
 Figure 18. Global Prostacyclin Sales Volume Market Share by Type, 2024 & 2031
 Figure 19. Global Prostacyclin Price by Type (2020-2031) & (USD/Unit)
 Figure 20. Product Picture of For Injection
 Figure 21. Product Picture of For Oral
 Figure 22. Product Picture of For Inhalation
 Figure 23. Global Prostacyclin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 24. Global Prostacyclin Sales Value Market Share by Application, 2024 & 2031
 Figure 25. Global Prostacyclin Sales Volume by Application (2020 VS 2024 VS 2031) & (K Unit)
 Figure 26. Global Prostacyclin Sales Volume Market Share by Application, 2024 & 2031
 Figure 27. Global Prostacyclin Price by Application (2020-2031) & (USD/Unit)
 Figure 28. North America Prostacyclin Sales Value (2020-2031) & (US$ Million)
 Figure 29. North America Prostacyclin Sales Value by Country (%), 2024 VS 2031
 Figure 30. Europe Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Europe Prostacyclin Sales Value by Country (%), 2024 VS 2031
 Figure 32. Asia Pacific Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Prostacyclin Sales Value by Region (%), 2024 VS 2031
 Figure 34. South America Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 35. South America Prostacyclin Sales Value by Country (%), 2024 VS 2031
 Figure 36. Middle East & Africa Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 37. Middle East & Africa Prostacyclin Sales Value by Country (%), 2024 VS 2031
 Figure 38. Key Countries/Regions Prostacyclin Sales Value (%), (2020-2031)
 Figure 39. Key Countries/Regions Prostacyclin Sales Volume (%), (2020-2031)
 Figure 40. United States Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 41. United States Prostacyclin Sales Value by Type (%), 2024 VS 2031
 Figure 42. United States Prostacyclin Sales Value by Application (%), 2024 VS 2031
 Figure 43. Europe Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Europe Prostacyclin Sales Value by Type (%), 2024 VS 2031
 Figure 45. Europe Prostacyclin Sales Value by Application (%), 2024 VS 2031
 Figure 46. China Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 47. China Prostacyclin Sales Value by Type (%), 2024 VS 2031
 Figure 48. China Prostacyclin Sales Value by Application (%), 2024 VS 2031
 Figure 49. Japan Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Japan Prostacyclin Sales Value by Type (%), 2024 VS 2031
 Figure 51. Japan Prostacyclin Sales Value by Application (%), 2024 VS 2031
 Figure 52. South Korea Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 53. South Korea Prostacyclin Sales Value by Type (%), 2024 VS 2031
 Figure 54. South Korea Prostacyclin Sales Value by Application (%), 2024 VS 2031
 Figure 55. Southeast Asia Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 56. Southeast Asia Prostacyclin Sales Value by Type (%), 2024 VS 2031
 Figure 57. Southeast Asia Prostacyclin Sales Value by Application (%), 2024 VS 2031
 Figure 58. India Prostacyclin Sales Value, (2020-2031) & (US$ Million)
 Figure 59. India Prostacyclin Sales Value by Type (%), 2024 VS 2031
 Figure 60. India Prostacyclin Sales Value by Application (%), 2024 VS 2031
 Figure 61. Prostacyclin Industrial Chain
 Figure 62. Prostacyclin Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Prostaglandin Market Research Report 2025
Prostaglandins and Related Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostacyclin Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostaglandin I2 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Indometacin Indomethacin Market Research Report 2024
Global Indomethacin Tablets Market Research Report 2024
Global Arachidonic Acid Market Research Report 2024
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
Global Cyclooxygenase 2 Inhibitor Market Research Report 2024
Global Specific COX 2 Inhibitors Market Research Report 2024
Global Pets NSAIDs Market Research Report 2025
Global Cyclooxygenase 2 Inhibitor COVID 19 Market Research Report 2024
Global Indomethacin Market Research Report 2024
Global Indometacin Patches Market Research Report 2024
Global PG Hormone Market Research Report 2025
Global Prostaglandin endoperoxide Synthase 2 COX 2 Protein Market Research Report 2024
Global Anti inflammatory Agents Market Research Report 2024
Non Steroidal Anti Inflammatory Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Prostaglandin endoperoxide Synthase 2 COX 2 Antibody Market Research Report 2024

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions